Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.7B | 20.2B | 21.2B | 21.1B |
Cost of revenue | 13.5B | 16.5B | 13.2B | 13.1B |
Gross profit | 8.3B | 3.7B | 7.9B | 7.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.0B | -1.4B | 2.8B | 2.7B |
Operating income | 3.1B | 2.9B | 3.0B | 3.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 15.6M | -400K | 10.6M | 15.9M |
Other income expense | — | — | — | — |
Pretax income | 3.4B | 3.3B | 3.2B | 3.3B |
Tax provision | 901.1M | 889.4M | 855.8M | 863.9M |
Net income | 2.5B | 2.4B | 2.4B | 2.5B |
Basic EPS | 16.1 | — | 15.1 | 15.7 |
Diluted EPS | 16.1 | — | 15.1 | 15.7 |
Basic average shares | 156.3M | — | 156.6M | 156.3M |
Diluted average shares | 156.3M | — | 156.6M | 156.3M |
EBITDA | 4.3B | 4.0B | 4.0B | 4.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |